Abstract | OBJECTIVES: METHODS: Overall, 1460 BC patients received AC (Study 1) or non-AC (Study 2) therapy over 6060 cycles. Randomized patients received DEX with either NEPA or oral PALO (Study 1), or NEPA or aprepitant+oral PALO (Study 2) before chemotherapy. RESULTS: In AC-receiving patients, overall complete response (CR) rates with NEPA+DEX were statistically significantly higher than oral PALO+DEX rates (cycles 1-4: 73.9% vs 65.9%, 80.0% vs 66.0%, 83.6% vs 69.9%, 83.6% vs 74.4%, respectively). Overall, no significant nausea (NSN) rates were also superior with NEPA+DEX vs oral PALO+DEX (respectively, 74.2%-79.9% vs 68.5%-74.9%). A greater proportion of NEPA+DEX patients experienced "no-impact-on-daily-life" due to CINV (78.4% vs 71.4%) in cycle 1. In non-AC-receiving patients, prophylaxis with NEPA+DEX resulted in high CR and NSN rates across 1-4 chemotherapy cycles; no formal comparison with the control arm was performed. CONCLUSION: NEPA+DEX administered as a single dose is an effective option for preventing CINV in BC patients receiving AC and non-AC, across multiple chemotherapy cycles. CLINICAL TRIALS REGISTRATION NUMBERS: Study 1: NCT01339260, Study 2:NCT01376297.
|
Authors | Hope S Rugo, Giorgia Rossi, Giada Rizzi, Matti Aapro |
Journal | Breast (Edinburgh, Scotland)
(Breast)
Vol. 33
Pg. 76-82
(Jun 2017)
ISSN: 1532-3080 [Electronic] Netherlands |
PMID | 28285236
(Publication Type: Journal Article, Meta-Analysis)
|
Copyright | Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. |
Chemical References |
- Anthracyclines
- Antiemetics
- Drug Combinations
- Isoquinolines
- Pyridines
- Quinuclidines
- netupitant, palosentron drug combination
- Dexamethasone
- Cyclophosphamide
|
Topics |
- Adult
- Aged
- Anthracyclines
(adverse effects)
- Antiemetics
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
(drug therapy)
- Clinical Trials, Phase III as Topic
- Cyclophosphamide
(adverse effects)
- Dexamethasone
(administration & dosage)
- Double-Blind Method
- Drug Combinations
- Female
- Humans
- Isoquinolines
(administration & dosage)
- Middle Aged
- Nausea
(chemically induced, prevention & control)
- Pyridines
(administration & dosage)
- Quinuclidines
(administration & dosage)
- Treatment Outcome
- Vomiting
(chemically induced, prevention & control)
- Young Adult
|